1 Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry[J]. Circ Res, 2003, 92(8): 827-839.
[2]
2 Galis ZS, Khatri JJ. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly[J]. Circ Res, 2002, 90(3): 251-262.
[3]
3 Jacob-Ferreira AL, Schulz R. Activation of intracellular matrix metalloproteinase-2 by reactive oxygen-nitrogen species: consequences and therapeutic strategies in the heart[J]. Arch Biochem Biophys, 2013, 540(1/2): 82-93.
[4]
4 Horstmann S, Kalb P, Koziol J, et al. Profiles of matrix metalloproteinases, their inhibitors, and laminin in stroke patients: influence of different therapies[J]. Stroke, 2003, 34(9): 2165-2170.
[5]
5 Montaner J, Molina CA, Monasterio J, et al. Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke[J]. Circulation, 2003, 107(4): 598-603.
9 Akamatsu Y, Saito A, Fujimura M, et al. Stachybotrys microspora triprenyl phenol-7, a novel fibrinolytic agent, suppresses superoxide production, matrix metalloproteinase-9 expression, and thereby attenuates ischemia/reperfusion injury in rat brain[J]. Neurosci Lett, 2011, 503(2): 110-114.
[10]
10 Brouns R, Wauters A, De Surgeloose D, et al. Biochemical markers for blood-brain barrier dysfunction in acute ischemic stroke correlate with evolution and outcome[J]. Eur Neurol, 2011, 65(1): 23-31.
12 Chang DI, Hosomi N, Lucero J, et al. Activation systems for latent matrix metalloproteinase-2 are upregulated immediately after focal cerebral ischemia[J]. J Cereb Blood Flow Metab, 2003, 23(12): 1408-1419.
13 Magnoni S, Baker A, George SJ, et al. Differential alterations in the expression and activity of matrix metalloproteinases 2 and 9 after transient cerebral ischemia in mice[J]. Neurobiol Dis, 2004, 17(2): 188-197.
[17]
14 Guo M, Cox B, Mahale S, et al. Pre-ischemic exercise reduces matrix metalloproteinase-9 expression and ameliorates blood-brain barrier dysfunction in stroke[J]. Neuroscience, 2008, 151(2): 340-351.
[18]
15 Brouns R, Wauters A, De Surgeloose D, et al. Biochemical markers for blood-brain barrier dysfunction in acute ischemic stroke correlate with evolution and outcome[J]. Eur Neurol, 2011, 65(1): 23-31.
